Evaluation of Dyspepsia Drug Use Patterns Based on WHO Indicators in Outpatients at Sengkol Health Center
DOI:
https://doi.org/10.37824/sh2tdx32Keywords:
Drug utilization, Dyspepsia, Rational use of medicine, Sengkol Health Center, WHO indicatorsAbstract
Dyspepsia is a common digestive disorder frequently encountered in primary health care. Rational drug use is essential to improve therapy outcomes and prevent risks related to polypharmacy. This study evaluated the prescribing patterns of dyspepsia drugs based on World Health Organization (WHO) indicators among outpatients at Sengkol Health Center, Pujut District, during January–May 2025. A descriptive quantitative design was applied using purposive sampling, involving 77 patients who met inclusion criteria. Data were analyzed based on five WHO prescribing indicators: average number of drugs per prescription, percentage of drugs prescribed by generic name, percentage of prescriptions containing antibiotics, percentage of prescriptions with injection drugs, and percentage of drugs consistent with the National Formulary (Fornas). The findings revealed that the average number of drugs per prescription was 2.6, higher than WHO’s recommended standard of 1.6–1.8, indicating a tendency toward polypharmacy. Meanwhile, 100% of drugs were prescribed using generic names and aligned with Fornas. Antibiotic use was 2.6%, below WHO’s reference value (20–26.8%), and no injections were prescribed (0%). These results suggest that overall prescribing practices were rational, with strong adherence to generic and formulary use, although the average number of drugs per prescription requires improvement. Continuous monitoring and evaluation are recommended to optimize rational drug use in primary care settings
References
[1] Purnamasari, Dispepsia: Diagnosis dan Tatalaksana. Jakarta: EGC, 2017.
[2] World Health Organization, Global Report on Dyspepsia Prevalence. Geneva: WHO, 2015.
[3] F. Andika, “Faktor risiko kejadian dispepsia di Indonesia,” Jurnal Ilmu Kesehatan, vol. 9, no. 1, pp. 55–63, 2023.
[4] World Health Organization, How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators. Geneva: WHO, 1993.
[5] A. Bakarbessy, “Peran WHO dalam kesehatan global,” Jurnal Administrasi Publik, vol. 9, no. 1, pp. 44–52, 2021.
[6] Kementerian Kesehatan RI, Formularium Nasional Edisi 2023. Jakarta: Kemenkes RI, 2023.
[7]. D. Sari, A. Putri, and B. Prasetyo, “Evaluasi peresepan obat berdasarkan indikator WHO di Puskesmas Karanganyar,” ResearchGate, 2024.
[8] N. Mayani, Evaluasi Pola Penggunaan Obat Dispepsia Berdasarkan Indikator WHO pada Pasien Rawat Jalan Puskesmas Sengkol Skripsi, Universitas Qamarul Huda Badaruddin Bagu, 2025.
[9] R. Gusti Mulandani, A. Hadriyanti, and R. Rahmadevi, “Pola penggunaan obat dispepsia rawat jalan di RSUD H. Abdul Manap Jambi,” Jurnal Farmasi, vol. 5, no. 2, pp. 112–118, 2020.
[10] J. F. Medistra, “Profile of suitability of BPJS patient drug prescription with the National Formularium at Juata Community Health Center,” Jurnal Farmasi Medistra, vol. 5, no. 2, pp. 158–165, 2024.
[11] R. Ade, “Hubungan konsumsi OAINS jangka panjang dengan risiko dispepsia,” Jurnal Farmasi Indonesia, vol. 9, no. 1, pp. 71–78, 2018.
[12] L. Musnelina and D. G. A. R. Ar, “Profil kesesuaian terapi obat dispepsia terhadap formularium,” Jurnal Penyakit Dalam, vol. 7, no. 2, pp. 55–62, 2019.
[13] N. Suardini, Penatalaksanaan dispepsia dengan terapi farmakologi dan nonfarmakologi,” Jurnal Farmasi Klinik, vol. 6, no. 3, pp. 112–120, 2021. [14]. W. Zakiyah, “Klarifikasi dispepsia menurut Konsensus Roma IV,” Jurnal Penyakit Dalam, vol. 8, no. 2, pp. 77– 84, 2021.
[15] A. Fithriyana, “Etiologi dispepsia dan faktor risiko,” Jurnal Kedokteran, vol. 5, no. 2, pp. 88–95, 2018
[16] I. D. N. Supariasa, Penilaian Status Gizi. Jakarta: EGC, 2016
